Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Histone acetyltransferase KAT6A (Homo sapiens) | BDBM534094![]() (WO2022081807, Example 201) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | WIPO WO2022081807 | n/a | n/a | 0.810 | n/a | n/a | n/a | n/a | n/a | n/a |
THE BROAD INSTITUTE, INC. WIPO | Assay Description Kat6a inhibitory activities of the compounds described in the present invention were quantified using a Fluorescence Resonance Energy Transfer (TR-FR... | WIPO WO2022081807 (2022) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Histone acetyltransferase KAT6A (Homo sapiens) | BDBM533971![]() (WO2022081807, Example 78) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | WIPO WO2022081807 | n/a | n/a | 1.41 | n/a | n/a | n/a | n/a | n/a | n/a |
THE BROAD INSTITUTE, INC. WIPO | Assay Description Kat6a inhibitory activities of the compounds described in the present invention were quantified using a Fluorescence Resonance Energy Transfer (TR-FR... | WIPO WO2022081807 (2022) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Histone acetyltransferase KAT6A (Homo sapiens) | BDBM533872![]() (WO2022081807, Example 5) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | WIPO WO2022081807 | n/a | n/a | 1.42 | n/a | n/a | n/a | n/a | n/a | n/a |
THE BROAD INSTITUTE, INC. WIPO | Assay Description Kat6a inhibitory activities of the compounds described in the present invention were quantified using a Fluorescence Resonance Energy Transfer (TR-FR... | WIPO WO2022081807 (2022) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Histone acetyltransferase KAT6A (Homo sapiens) | BDBM534119![]() (WO2022081807, Example 226) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | WIPO WO2022081807 | n/a | n/a | 1.79 | n/a | n/a | n/a | n/a | n/a | n/a |
THE BROAD INSTITUTE, INC. WIPO | Assay Description Kat6a inhibitory activities of the compounds described in the present invention were quantified using a Fluorescence Resonance Energy Transfer (TR-FR... | WIPO WO2022081807 (2022) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Histone acetyltransferase KAT6A (Homo sapiens) | BDBM534100![]() (WO2022081807, Example 207) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | WIPO WO2022081807 | n/a | n/a | 1.86 | n/a | n/a | n/a | n/a | n/a | n/a |
THE BROAD INSTITUTE, INC. WIPO | Assay Description Kat6a inhibitory activities of the compounds described in the present invention were quantified using a Fluorescence Resonance Energy Transfer (TR-FR... | WIPO WO2022081807 (2022) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Histone acetyltransferase KAT6A (Homo sapiens) | BDBM534121![]() (WO2022081807, Example 228) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | WIPO WO2022081807 | n/a | n/a | 2.57 | n/a | n/a | n/a | n/a | n/a | n/a |
THE BROAD INSTITUTE, INC. WIPO | Assay Description Kat6a inhibitory activities of the compounds described in the present invention were quantified using a Fluorescence Resonance Energy Transfer (TR-FR... | WIPO WO2022081807 (2022) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Histone acetyltransferase KAT6A (Homo sapiens) | BDBM534117![]() (WO2022081807, Example 224) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | WIPO WO2022081807 | n/a | n/a | 3.72 | n/a | n/a | n/a | n/a | n/a | n/a |
THE BROAD INSTITUTE, INC. WIPO | Assay Description Kat6a inhibitory activities of the compounds described in the present invention were quantified using a Fluorescence Resonance Energy Transfer (TR-FR... | WIPO WO2022081807 (2022) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Histone acetyltransferase KAT6A (Homo sapiens) | BDBM534118![]() (6-(Azetidin-1-yl)-N-[(2-(benzyloxy)-5-(tert-butyl)...) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | WIPO WO2022081807 | n/a | n/a | 3.72 | n/a | n/a | n/a | n/a | n/a | n/a |
THE BROAD INSTITUTE, INC. WIPO | Assay Description Kat6a inhibitory activities of the compounds described in the present invention were quantified using a Fluorescence Resonance Energy Transfer (TR-FR... | WIPO WO2022081807 (2022) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Histone acetyltransferase KAT6A (Homo sapiens) | BDBM534107![]() (6-(azetidin-1-yl)-N-[2-(cyclopropylmethoxy)-5-isop...) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | WIPO WO2022081807 | n/a | n/a | 3.91 | n/a | n/a | n/a | n/a | n/a | n/a |
THE BROAD INSTITUTE, INC. WIPO | Assay Description Kat6a inhibitory activities of the compounds described in the present invention were quantified using a Fluorescence Resonance Energy Transfer (TR-FR... | WIPO WO2022081807 (2022) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Histone acetyltransferase KAT6A (Homo sapiens) | BDBM533874![]() (WO2022081807, Example 7) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | WIPO WO2022081807 | n/a | n/a | 4.15 | n/a | n/a | n/a | n/a | n/a | n/a |
THE BROAD INSTITUTE, INC. WIPO | Assay Description Kat6a inhibitory activities of the compounds described in the present invention were quantified using a Fluorescence Resonance Energy Transfer (TR-FR... | WIPO WO2022081807 (2022) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Histone acetyltransferase KAT6A (Homo sapiens) | BDBM534087![]() (6-(Azetidin-1-yl)-N-[5-(3,5-dimethyl-1,2-oxazol-4-...) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | WIPO WO2022081807 | n/a | n/a | 4.19 | n/a | n/a | n/a | n/a | n/a | n/a |
THE BROAD INSTITUTE, INC. WIPO | Assay Description Kat6a inhibitory activities of the compounds described in the present invention were quantified using a Fluorescence Resonance Energy Transfer (TR-FR... | WIPO WO2022081807 (2022) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Histone acetyltransferase KAT6A (Homo sapiens) | BDBM534124![]() (6-(Azetidin-1-yl)-N-((2-((2,2-difluorocyclopropyl)...) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | WIPO WO2022081807 | n/a | n/a | 4.22 | n/a | n/a | n/a | n/a | n/a | n/a |
THE BROAD INSTITUTE, INC. WIPO | Assay Description Kat6a inhibitory activities of the compounds described in the present invention were quantified using a Fluorescence Resonance Energy Transfer (TR-FR... | WIPO WO2022081807 (2022) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Histone acetyltransferase KAT6A (Homo sapiens) | BDBM534043![]() (WO2022081807, Example 150) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | WIPO WO2022081807 | n/a | n/a | 4.25 | n/a | n/a | n/a | n/a | n/a | n/a |
THE BROAD INSTITUTE, INC. WIPO | Assay Description Kat6a inhibitory activities of the compounds described in the present invention were quantified using a Fluorescence Resonance Energy Transfer (TR-FR... | WIPO WO2022081807 (2022) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Histone acetyltransferase KAT6A (Homo sapiens) | BDBM533884![]() (6-(Azetidin-1-yl)-N-(2,6-dipropoxybenzene-1-sulfon...) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | WIPO WO2022081807 | n/a | n/a | 4.47 | n/a | n/a | n/a | n/a | n/a | n/a |
THE BROAD INSTITUTE, INC. WIPO | Assay Description Kat6a inhibitory activities of the compounds described in the present invention were quantified using a Fluorescence Resonance Energy Transfer (TR-FR... | WIPO WO2022081807 (2022) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Histone acetyltransferase KAT6A (Homo sapiens) | BDBM534006![]() (N-(5-tert-butyl-2-ethoxybenzene-1-sulfonyl)-4-fluo...) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | WIPO WO2022081807 | n/a | n/a | 4.48 | n/a | n/a | n/a | n/a | n/a | n/a |
THE BROAD INSTITUTE, INC. WIPO | Assay Description Kat6a inhibitory activities of the compounds described in the present invention were quantified using a Fluorescence Resonance Energy Transfer (TR-FR... | WIPO WO2022081807 (2022) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Histone acetyltransferase KAT6A (Homo sapiens) | BDBM534020![]() (6-(Azetidin-1-yl)-N-(5-tert-butyl-2-methoxybenzene...) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | WIPO WO2022081807 | n/a | n/a | 4.53 | n/a | n/a | n/a | n/a | n/a | n/a |
THE BROAD INSTITUTE, INC. WIPO | Assay Description Kat6a inhibitory activities of the compounds described in the present invention were quantified using a Fluorescence Resonance Energy Transfer (TR-FR... | WIPO WO2022081807 (2022) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Histone acetyltransferase KAT6A (Homo sapiens) | BDBM534122![]() (6-(Azetidin-1-yl)-N-[(5-(tert-butyl)-2-isopropoxyp...) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | WIPO WO2022081807 | n/a | n/a | 4.79 | n/a | n/a | n/a | n/a | n/a | n/a |
THE BROAD INSTITUTE, INC. WIPO | Assay Description Kat6a inhibitory activities of the compounds described in the present invention were quantified using a Fluorescence Resonance Energy Transfer (TR-FR... | WIPO WO2022081807 (2022) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Histone acetyltransferase KAT6A (Homo sapiens) | BDBM534088![]() (WO2022081807, Example 195) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | WIPO WO2022081807 | n/a | n/a | 5.07 | n/a | n/a | n/a | n/a | n/a | n/a |
THE BROAD INSTITUTE, INC. WIPO | Assay Description Kat6a inhibitory activities of the compounds described in the present invention were quantified using a Fluorescence Resonance Energy Transfer (TR-FR... | WIPO WO2022081807 (2022) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Histone acetyltransferase KAT6A (Homo sapiens) | BDBM534120![]() (6-(Azetidin-1-yl)-N-[(5-(tert-butyl)-2-(2,2,2-trif...) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | WIPO WO2022081807 | n/a | n/a | 5.40 | n/a | n/a | n/a | n/a | n/a | n/a |
THE BROAD INSTITUTE, INC. WIPO | Assay Description Kat6a inhibitory activities of the compounds described in the present invention were quantified using a Fluorescence Resonance Energy Transfer (TR-FR... | WIPO WO2022081807 (2022) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Histone acetyltransferase KAT6B (Homo sapiens) | BDBM534100![]() (WO2022081807, Example 207) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank GoogleScholar | UniChem | WIPO WO2022081807 | n/a | n/a | 5.65 | n/a | n/a | n/a | n/a | n/a | n/a |
THE BROAD INSTITUTE, INC. WIPO | Assay Description Kat6b inhibitory activities of the compounds described in the present invention were quantified using a Fluorescence Resonance Energy Transfer (TR-FR... | WIPO WO2022081807 (2022) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Histone acetyltransferase KAT6B (Homo sapiens) | BDBM534020![]() (6-(Azetidin-1-yl)-N-(5-tert-butyl-2-methoxybenzene...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank GoogleScholar | UniChem | WIPO WO2022081807 | n/a | n/a | 5.67 | n/a | n/a | n/a | n/a | n/a | n/a |
THE BROAD INSTITUTE, INC. WIPO | Assay Description Kat6b inhibitory activities of the compounds described in the present invention were quantified using a Fluorescence Resonance Energy Transfer (TR-FR... | WIPO WO2022081807 (2022) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Histone acetyltransferase KAT6A (Homo sapiens) | BDBM534044![]() (N-[2-ethoxy-5-(propan-2-yl)benzene-1 -sulfonyl]-4-...) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | WIPO WO2022081807 | n/a | n/a | 5.81 | n/a | n/a | n/a | n/a | n/a | n/a |
THE BROAD INSTITUTE, INC. WIPO | Assay Description Kat6a inhibitory activities of the compounds described in the present invention were quantified using a Fluorescence Resonance Energy Transfer (TR-FR... | WIPO WO2022081807 (2022) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Histone acetyltransferase KAT6A (Homo sapiens) | BDBM534090![]() (WO2022081807, Example 197) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | WIPO WO2022081807 | n/a | n/a | 6.06 | n/a | n/a | n/a | n/a | n/a | n/a |
THE BROAD INSTITUTE, INC. WIPO | Assay Description Kat6a inhibitory activities of the compounds described in the present invention were quantified using a Fluorescence Resonance Energy Transfer (TR-FR... | WIPO WO2022081807 (2022) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Histone acetyltransferase KAT6A (Homo sapiens) | BDBM534106![]() (WO2022081807, Example 213) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | WIPO WO2022081807 | n/a | n/a | 6.18 | n/a | n/a | n/a | n/a | n/a | n/a |
THE BROAD INSTITUTE, INC. WIPO | Assay Description Kat6a inhibitory activities of the compounds described in the present invention were quantified using a Fluorescence Resonance Energy Transfer (TR-FR... | WIPO WO2022081807 (2022) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Histone acetyltransferase KAT6A (Homo sapiens) | BDBM533877![]() (WO2022081807, Example 10) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | WIPO WO2022081807 | n/a | n/a | 7.12 | n/a | n/a | n/a | n/a | n/a | n/a |
THE BROAD INSTITUTE, INC. WIPO | Assay Description Kat6a inhibitory activities of the compounds described in the present invention were quantified using a Fluorescence Resonance Energy Transfer (TR-FR... | WIPO WO2022081807 (2022) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Histone acetyltransferase KAT6A (Homo sapiens) | BDBM534108![]() (WO2022081807, Example 215) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | WIPO WO2022081807 | n/a | n/a | 7.18 | n/a | n/a | n/a | n/a | n/a | n/a |
THE BROAD INSTITUTE, INC. WIPO | Assay Description Kat6a inhibitory activities of the compounds described in the present invention were quantified using a Fluorescence Resonance Energy Transfer (TR-FR... | WIPO WO2022081807 (2022) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Histone acetyltransferase KAT6A (Homo sapiens) | BDBM533878![]() (6-(Azetidin-1-yl)-N-[2-(dimethylamino)benzene-1-su...) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | WIPO WO2022081807 | n/a | n/a | 7.52 | n/a | n/a | n/a | n/a | n/a | n/a |
THE BROAD INSTITUTE, INC. WIPO | Assay Description Kat6a inhibitory activities of the compounds described in the present invention were quantified using a Fluorescence Resonance Energy Transfer (TR-FR... | WIPO WO2022081807 (2022) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Histone acetyltransferase KAT6A (Homo sapiens) | BDBM534104![]() (WO2022081807, Example 211) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | WIPO WO2022081807 | n/a | n/a | 7.58 | n/a | n/a | n/a | n/a | n/a | n/a |
THE BROAD INSTITUTE, INC. WIPO | Assay Description Kat6a inhibitory activities of the compounds described in the present invention were quantified using a Fluorescence Resonance Energy Transfer (TR-FR... | WIPO WO2022081807 (2022) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Histone acetyltransferase KAT6A (Homo sapiens) | BDBM534097![]() (6-(Azetidin-1-yl)-4-fluoro-N-(2,2,5,6-tetramethyl-...) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | WIPO WO2022081807 | n/a | n/a | 7.70 | n/a | n/a | n/a | n/a | n/a | n/a |
THE BROAD INSTITUTE, INC. WIPO | Assay Description Kat6a inhibitory activities of the compounds described in the present invention were quantified using a Fluorescence Resonance Energy Transfer (TR-FR... | WIPO WO2022081807 (2022) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Histone acetyltransferase KAT6A (Homo sapiens) | BDBM534123![]() (WO2022081807, Example 230) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | WIPO WO2022081807 | n/a | n/a | 7.71 | n/a | n/a | n/a | n/a | n/a | n/a |
THE BROAD INSTITUTE, INC. WIPO | Assay Description Kat6a inhibitory activities of the compounds described in the present invention were quantified using a Fluorescence Resonance Energy Transfer (TR-FR... | WIPO WO2022081807 (2022) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Histone acetyltransferase KAT6A (Homo sapiens) | BDBM534098![]() (WO2022081807, Example 205) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | WIPO WO2022081807 | n/a | n/a | 7.97 | n/a | n/a | n/a | n/a | n/a | n/a |
THE BROAD INSTITUTE, INC. WIPO | Assay Description Kat6a inhibitory activities of the compounds described in the present invention were quantified using a Fluorescence Resonance Energy Transfer (TR-FR... | WIPO WO2022081807 (2022) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Histone acetyltransferase KAT6A (Homo sapiens) | BDBM533868![]() (WO2022081807, Example 3) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | WIPO WO2022081807 | n/a | n/a | 8.10 | n/a | n/a | n/a | n/a | n/a | n/a |
THE BROAD INSTITUTE, INC. WIPO | Assay Description Kat6a inhibitory activities of the compounds described in the present invention were quantified using a Fluorescence Resonance Energy Transfer (TR-FR... | WIPO WO2022081807 (2022) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Histone acetyltransferase KAT6A (Homo sapiens) | BDBM534021![]() (WO2022081807, Example 128) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | WIPO WO2022081807 | n/a | n/a | 8.15 | n/a | n/a | n/a | n/a | n/a | n/a |
THE BROAD INSTITUTE, INC. WIPO | Assay Description Kat6a inhibitory activities of the compounds described in the present invention were quantified using a Fluorescence Resonance Energy Transfer (TR-FR... | WIPO WO2022081807 (2022) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Histone acetyltransferase KAT6A (Homo sapiens) | BDBM534089![]() (6-(azetidin-1-yl)-N-[5-(3,6-dihydro-2H-pyran-4-yl)...) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | WIPO WO2022081807 | n/a | n/a | 8.25 | n/a | n/a | n/a | n/a | n/a | n/a |
THE BROAD INSTITUTE, INC. WIPO | Assay Description Kat6a inhibitory activities of the compounds described in the present invention were quantified using a Fluorescence Resonance Energy Transfer (TR-FR... | WIPO WO2022081807 (2022) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Histone acetyltransferase KAT6A (Homo sapiens) | BDBM534082![]() (6-(Azetidin-1-yl)-N-(5-tert-butyl-2,3-dimethylbenz...) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | WIPO WO2022081807 | n/a | n/a | 8.59 | n/a | n/a | n/a | n/a | n/a | n/a |
THE BROAD INSTITUTE, INC. WIPO | Assay Description Kat6a inhibitory activities of the compounds described in the present invention were quantified using a Fluorescence Resonance Energy Transfer (TR-FR... | WIPO WO2022081807 (2022) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Histone acetyltransferase KAT6A (Homo sapiens) | BDBM533866![]() (6-(Azetidin-1 -yl)-N-(2-ethoxy-6-methoxybenzene-1 ...) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | WIPO WO2022081807 | n/a | n/a | 8.61 | n/a | n/a | n/a | n/a | n/a | n/a |
THE BROAD INSTITUTE, INC. WIPO | Assay Description Kat6a inhibitory activities of the compounds described in the present invention were quantified using a Fluorescence Resonance Energy Transfer (TR-FR... | WIPO WO2022081807 (2022) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Histone acetyltransferase KAT6A (Homo sapiens) | BDBM533869![]() (6-(Azetidin-1-yl)-N-(2-{[butan-2-yl]oxy}-5-methylb...) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | WIPO WO2022081807 | n/a | n/a | 8.72 | n/a | n/a | n/a | n/a | n/a | n/a |
THE BROAD INSTITUTE, INC. WIPO | Assay Description Kat6a inhibitory activities of the compounds described in the present invention were quantified using a Fluorescence Resonance Energy Transfer (TR-FR... | WIPO WO2022081807 (2022) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Histone acetyltransferase KAT6A (Homo sapiens) | BDBM533972![]() (6-(Azetidin-1-yl)-4-fluoro-N-[3-(propan-2-yl)pyrid...) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | WIPO WO2022081807 | n/a | n/a | 9.58 | n/a | n/a | n/a | n/a | n/a | n/a |
THE BROAD INSTITUTE, INC. WIPO | Assay Description Kat6a inhibitory activities of the compounds described in the present invention were quantified using a Fluorescence Resonance Energy Transfer (TR-FR... | WIPO WO2022081807 (2022) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Histone acetyltransferase KAT6B (Homo sapiens) | BDBM534117![]() (WO2022081807, Example 224) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank GoogleScholar | UniChem | WIPO WO2022081807 | n/a | n/a | 9.82 | n/a | n/a | n/a | n/a | n/a | n/a |
THE BROAD INSTITUTE, INC. WIPO | Assay Description Kat6b inhibitory activities of the compounds described in the present invention were quantified using a Fluorescence Resonance Energy Transfer (TR-FR... | WIPO WO2022081807 (2022) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Histone acetyltransferase KAT6B (Homo sapiens) | BDBM534118![]() (6-(Azetidin-1-yl)-N-[(2-(benzyloxy)-5-(tert-butyl)...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank GoogleScholar | UniChem | WIPO WO2022081807 | n/a | n/a | 9.82 | n/a | n/a | n/a | n/a | n/a | n/a |
THE BROAD INSTITUTE, INC. WIPO | Assay Description Kat6b inhibitory activities of the compounds described in the present invention were quantified using a Fluorescence Resonance Energy Transfer (TR-FR... | WIPO WO2022081807 (2022) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Histone acetyltransferase KAT6A (Homo sapiens) | BDBM534046![]() (N-(2-ethoxy-5-ethylbenzene-1 -sulfonyl)-4-fluoro-6...) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | WIPO WO2022081807 | n/a | n/a | 11 | n/a | n/a | n/a | n/a | n/a | n/a |
THE BROAD INSTITUTE, INC. WIPO | Assay Description Kat6a inhibitory activities of the compounds described in the present invention were quantified using a Fluorescence Resonance Energy Transfer (TR-FR... | WIPO WO2022081807 (2022) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Histone acetyltransferase KAT6A (Homo sapiens) | BDBM534062![]() (WO2022081807, Example 169 | WO2022081807, Example ...) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | WIPO WO2022081807 | n/a | n/a | 11 | n/a | n/a | n/a | n/a | n/a | n/a |
THE BROAD INSTITUTE, INC. WIPO | Assay Description Kat6a inhibitory activities of the compounds described in the present invention were quantified using a Fluorescence Resonance Energy Transfer (TR-FR... | WIPO WO2022081807 (2022) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Histone acetyltransferase KAT6A (Homo sapiens) | BDBM533973![]() (WO2022081807, Example 80) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | WIPO WO2022081807 | n/a | n/a | 12 | n/a | n/a | n/a | n/a | n/a | n/a |
THE BROAD INSTITUTE, INC. WIPO | Assay Description Kat6a inhibitory activities of the compounds described in the present invention were quantified using a Fluorescence Resonance Energy Transfer (TR-FR... | WIPO WO2022081807 (2022) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Histone acetyltransferase KAT6B (Homo sapiens) | BDBM534006![]() (N-(5-tert-butyl-2-ethoxybenzene-1-sulfonyl)-4-fluo...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank GoogleScholar | UniChem | WIPO WO2022081807 | n/a | n/a | 12 | n/a | n/a | n/a | n/a | n/a | n/a |
THE BROAD INSTITUTE, INC. WIPO | Assay Description Kat6b inhibitory activities of the compounds described in the present invention were quantified using a Fluorescence Resonance Energy Transfer (TR-FR... | WIPO WO2022081807 (2022) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Histone acetyltransferase KAT6A (Homo sapiens) | BDBM534091![]() (6-(Azetidin-1-yl)-4-fluoro-N-(3'-fluoro-4-methoxy[...) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | WIPO WO2022081807 | n/a | n/a | 12 | n/a | n/a | n/a | n/a | n/a | n/a |
THE BROAD INSTITUTE, INC. WIPO | Assay Description Kat6a inhibitory activities of the compounds described in the present invention were quantified using a Fluorescence Resonance Energy Transfer (TR-FR... | WIPO WO2022081807 (2022) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Histone acetyltransferase KAT6B (Homo sapiens) | BDBM534121![]() (WO2022081807, Example 228) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank GoogleScholar | UniChem | WIPO WO2022081807 | n/a | n/a | 13 | n/a | n/a | n/a | n/a | n/a | n/a |
THE BROAD INSTITUTE, INC. WIPO | Assay Description Kat6b inhibitory activities of the compounds described in the present invention were quantified using a Fluorescence Resonance Energy Transfer (TR-FR... | WIPO WO2022081807 (2022) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Histone acetyltransferase KAT6A (Homo sapiens) | BDBM534047![]() (WO2022081807, Example 154) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | WIPO WO2022081807 | n/a | n/a | 13 | n/a | n/a | n/a | n/a | n/a | n/a |
THE BROAD INSTITUTE, INC. WIPO | Assay Description Kat6a inhibitory activities of the compounds described in the present invention were quantified using a Fluorescence Resonance Energy Transfer (TR-FR... | WIPO WO2022081807 (2022) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Histone acetyltransferase KAT6A (Homo sapiens) | BDBM534023![]() (WO2022081807, Example 130) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | WIPO WO2022081807 | n/a | n/a | 14 | n/a | n/a | n/a | n/a | n/a | n/a |
THE BROAD INSTITUTE, INC. WIPO | Assay Description Kat6a inhibitory activities of the compounds described in the present invention were quantified using a Fluorescence Resonance Energy Transfer (TR-FR... | WIPO WO2022081807 (2022) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Histone acetyltransferase KAT6A (Homo sapiens) | BDBM534025![]() (WO2022081807, Example 132) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | WIPO WO2022081807 | n/a | n/a | 14 | n/a | n/a | n/a | n/a | n/a | n/a |
THE BROAD INSTITUTE, INC. WIPO | Assay Description Kat6a inhibitory activities of the compounds described in the present invention were quantified using a Fluorescence Resonance Energy Transfer (TR-FR... | WIPO WO2022081807 (2022) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Histone acetyltransferase KAT6A (Homo sapiens) | BDBM534045![]() (WO2022081807, Example 152) | PDB UniProtKB/SwissProt GoogleScholar | UniChem | WIPO WO2022081807 | n/a | n/a | 14 | n/a | n/a | n/a | n/a | n/a | n/a |
THE BROAD INSTITUTE, INC. WIPO | Assay Description Kat6a inhibitory activities of the compounds described in the present invention were quantified using a Fluorescence Resonance Energy Transfer (TR-FR... | WIPO WO2022081807 (2022) | |||||||||||
More data for this Ligand-Target Pair |
Displayed 1 to 50 (of 252 total ) | Next | Last >> |